Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: A randomized controlled trial

American Journal of Kidney Diseases

Volumn 61, Issue 4, 2013, Pages 588-597

  Goldstein, Stuart L ^a   Morris, David ^b   Warady, Bradley A ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b WebbWrites LLC   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

adolescents; anemia; children; chronic kidney disease; dialysis; Iron sucrose

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; IRON SACCHARATE; TRANSFERRIN;

ADOLESCENCE; ANEMIA; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; BLOOD PRESSURE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; COLD SWEAT; CONTROLLED STUDY; COUGHING; DRUG ERUPTION; DRUG INDUCED HEADACHE; HEMODIALYSIS; HUMAN; IRON DEFICIENCY ANEMIA; MULTICENTER STUDY; PERITONEAL DIALYSIS; PERITONITIS; PHASE 4 CLINICAL TRIAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; SKIN ALLERGY; SKIN IRRITATION; VOMITING;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; FERRIC COMPOUNDS; GLUCARIC ACID; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84875211632     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.10.019     Document Type: Article

References (40)

1. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease Am J Kidney Dis 47 5 2006 S11 S145 (suppl 3)
2. D.E. Muller-Wiefel, H. Sinn, G. Gilli, K. Scharer Hemolysis and blood loss in children with chronic renal failure Clin Nephrol 8 5 1977 481 486
3. A. Besarab, D.W. Coyne Iron supplementation to treat anemia in patients with chronic kidney disease Nat Rev Nephrol 6 12 2010 699 710
4. O. Bamgbola Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations Pediatr Nephrol 27 2 2012 195 205
5. I.C. Macdougall Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous? Curr Med Res Opin 26 2 2010 473 482
6. S. Fishbane, S. Pollack, H.I. Feldman, M.M. Joffe Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004 Clin J Am Soc Nephrol 4 1 2009 57 61
7. C. Charytan Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs Clin J Am Soc Nephrol 5 12 2010 2355 2362
8. W.C. Winkelmayer Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care Blood Purif 31 1-3 2011 66 69
9. J.B. Wish Anemia management under a bundled payment policy for dialysis: a preview for the United States from Japan Kidney Int 79 3 2011 265 267
10. National Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 update of hemoglobin target Am J Kidney Dis 50 3 2007 471 530
11. L.A. Greenbaum, C.G. Pan, C. Caley, T. Nelson, K.J. Sheth Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients Pediatr Nephrol 14 10-11 2000 908 911
12. B.A. Warady, A. Kausz, G. Lerner Iron therapy in the pediatric hemodialysis population Pediatr Nephrol 19 6 2004 655 661
13. S. Fishbane Safety in iron management Am J Kidney Dis 41 5 suppl 2003 18 26
14. G.R. Aronoff, W.M. Bennett, S. Blumenthal Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens Kidney Int 66 3 2004 1193 1198
15. B. Michael, D.W. Coyne, S. Fishbane Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran Kidney Int 61 5 2002 1830 1839
16. J. Yee, A. Besarab Iron sucrose: the oldest iron therapy becomes new Am J Kidney Dis 40 6 2002 1111 1121
17. W.L. St Peter, G.T. Obrador, T.L. Roberts, A.J. Collins Trends in intravenous iron use among dialysis patients in the United States (1994-2002) Am J Kidney Dis 46 4 2005 650 660
18. C. Charytan, N. Levin, M. Al-Saloum, T. Hafeez, S. Gagnon, D.B. Van Wyck Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial Am J Kidney Dis 37 2 2001 300 307
19. D.B. Van Wyck, G. Cavallo, B.S. Spinowitz Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial Am J Kidney Dis 36 1 2000 88 97
20. G. Mircescu, L. Garneata, C. Capusa, N. Ursea Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients Nephrol Dial Transplant 21 1 2006 120 124
21. D.B. Van Wyck, M. Roppolo, C.O. Martinez, R.M. Mazey, S. McMurray A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD Kidney Int 68 6 2005 2846 2856
22. D.S. Silverberg, A. Iaina, G. Peer Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis Am J Kidney Dis 27 2 1996 234 238
23. C.J. Wu, H.C. Lin, K.F. Lee, C.K. Chuang, Y.C. Chen, H.H. Chen Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients Nephrology (Carlton) 15 1 2010 42 47
24. H.E. Morgan, R.C. Holt, C.A. Jones, B.A. Judd Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin Pediatr Nephrol 22 11 2007 1963 1965
25. E. Leijn, L.A. Monnens, E.A. Cornelissen Intravenous iron supplementation in children on hemodialysis J Nephrol 17 3 2004 423 426
26. G.J. Schwartz, L.P. Brion, A. Spitzer The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents Pediatr Clin North Am 34 3 1987 571 590
27. A.S. Levey, J.P. Bosch, J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
28. H.E. Morgan, M. Gautam, D.F. Geary Maintenance intravenous iron therapy in pediatric hemodialysis patients Pediatr Nephrol 16 10 2001 779 783
29. A.J. Collins, R.N. Foley, C. Herzog Excerpts from the US Renal Data System 2009 Annual Data Report (suppl 1) Am J Kidney Dis 55 1 2010 S1 S420 A426-A427
30. Y. Zhang, M. Thamer, K. Stefanik, J. Kaufman, D.J. Cotter Epoetin requirements predict mortality in hemodialysis patients Am J Kidney Dis 44 5 2004 866 876
31. T.B. Drueke, F. Locatelli, N. Clyne Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 20 2006 2071 2084
32. A. Besarab, N. Amin, M. Ahsan Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients J Am Soc Nephrol 11 3 2000 530 538
33. A.K. Singh, L. Szczech, K.L. Tang Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 20 2006 2085 2098
34. L.A. Szczech, H.X. Barnhart, J.K. Inrig Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes Kidney Int 74 6 2008 791 798
35. B.A. Warady, R.H. Zobrist, J. Wu, E. Finan Sodium ferric gluconate complex therapy in anemic children on hemodialysis Pediatr Nephrol 20 9 2005 1320 1327
36. K. Tenbrock, J. Muller-Berghaus, D. Michalk, U. Querfeld Intravenous iron treatment of renal anemia in children on hemodialysis Pediatr Nephrol 13 7 1999 580 582
37. B.A. Warady, R.H. Zobrist, E. Finan Sodium ferric gluconate complex maintenance therapy in children on hemodialysis Pediatr Nephrol 21 4 2006 553 560
38. R.A. Zager, A.C. Johnson, S.Y. Hanson Parenteral iron nephrotoxicity: potential mechanisms and consequences Kidney Int 66 1 2004 144 156
39. R.A. Zager Intravenous iron therapy in peritoneal dialysis patients: short-term efficacy and long-term issues Clin J Am Soc Nephrol 1 3 2006 353 355
40. I.C. Macdougall, M. Ashenden Current and upcoming erythropoiesis- stimulating agents, iron products, and other novel anemia medications Adv Chronic Kidney Dis 16 2 2009 117 130